Dose-finding trial results presented this week for new fibrin-specific thrombolytic agent Sep. 4, 2001
HMR-1556 selectively blocks slow delayed rectifier potassium channel in cardiac myocytes Sep. 3, 2001
Add-on therapy with CHF-1035 associated with improvement in clinical indicators of heart failure Sep. 3, 2001
Collaborative investigations by Pfizer and Neurogen yield pyrazolopyrimidine NPY antagonists Sep. 3, 2001
RSS